Proprotein Convertase Subtilisin/Kexin Type 9: From Biology to Therapeutic Targeting in Cardiovascular Disease.
- DOI
- 10.1111/eci.70263
- Published
- 2026 Oct
- Container
- European journal of clinical investigation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/eci.70263,
title = {Proprotein Convertase Subtilisin/Kexin Type 9: From Biology to Therapeutic Targeting in Cardiovascular Disease.},
author = {Rizzo R and Daraban BS and Tudorache IF and Barbarossa D and Protopapa F and Zeynali A and Esposito FM and Catapano AL},
year = {2026},
journal = {European journal of clinical investigation},
doi = {10.1111/eci.70263},
url = {https://doi.org/10.1111/eci.70263}
}RIS
TY - JOUR TI - Proprotein Convertase Subtilisin/Kexin Type 9: From Biology to Therapeutic Targeting in Cardiovascular Disease. AU - Rizzo R AU - Daraban BS AU - Tudorache IF AU - Barbarossa D AU - Protopapa F AU - Zeynali A AU - Esposito FM AU - Catapano AL PY - 2026 JO - European journal of clinical investigation DO - 10.1111/eci.70263 UR - https://doi.org/10.1111/eci.70263 ER -
APA
R, R., BS, D., IF, T., D, B., F, P., A, Z., FM, E., & AL, C. (2026). Proprotein Convertase Subtilisin/Kexin Type 9: From Biology to Therapeutic Targeting in Cardiovascular Disease.. European journal of clinical investigation. https://doi.org/10.1111/eci.70263
Source records
- pubmed · retrieved 2026-11-10T13:36:16.143Z